Cheryl Tajon
cheryl@trilotherapeutics.com
Dr. Cheryl Tajon leads chemistry development at Trilo Therapeutics. She earned her Ph.D. in Chemistry and Chemical Biology at the University of California, San Francisco, followed by a post-doctoral fellowship in the Biological Nanostructures Facility at the Molecular Foundry. Her past research has focused on the technological development of nanoparticle sensors, as well as targeted inhibitors of prostate cancer based on novel peptidomimetics.
